Standout Papers

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphoc... 2011 2026 2016 2021 593
  1. Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765 (2011)
    Sarah E. M. Herman, Amber Gordon et al. Blood

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 65 standout
Sub-graph 1 of 19

Citing Papers

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis
2025 Standout
5 intermediate papers

Works of Sarah E. M. Herman being referenced

Treatment with Ibrutinib Inhibits BTK- and VLA-4–Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo
2015
Ibrutinib-induced lymphocytosis in patients with chronic lymphocytic leukemia: correlative analyses from a phase II study
2014
and 2 more

Author Peers

Author Last Decade Papers Cites
Sarah E. M. Herman 2080 1586 569 988 42 2.5k
Ahmed Hamdy 1903 1565 659 720 56 2.5k
Mariela Sivina 1466 932 461 768 38 1.9k
J L Binet 1804 1517 381 924 22 2.4k
Monica Else 1539 1172 314 701 42 1.9k
William G. Wierda 1715 1358 336 928 39 2.1k
Andreas Bühler 2113 1593 417 900 46 2.6k
Ellen Schlette 1307 1294 398 624 68 2.3k
Tarun Wasil 2413 1653 275 1337 18 2.7k
Ulrich Jäger 1417 1337 429 658 85 2.4k
Ilaria Del Giudice 1450 1225 289 750 83 1.9k

All Works

Loading papers...

Rankless by CCL
2026